Current Issue June 2012, Vol. 6, No. 5

Issue Highlights

Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures
June 2012(Vol. 6 | No. 5 | Pages 507-517)
Ulrike Achleitner, Michaela Coenen, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet, Narine Sahakyan, Alarcos Cieza

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
June 2012(Vol. 6 | No. 5 | Pages 518-523)
Iván Guerra, Alicia Algaba, José Lázaro Pérez-Calle, María Chaparro, Ignacio Marín-Jiménez, Raquel García-Castellanos, Yago González-Lama, Antonio López-Sanromán, Noemí Manceñido, Pilar Martínez-Montiel, Elvira Quintanilla, Carlos Taxonera, Mónica Villafruela, Alberto Romero-Maté, Pilar López-Serrano, Javier P. Gisbert, Fernando Bermejo

Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland
June 2012(Vol. 6 | No. 5 | Pages 524-528)
Pia Manninen, Anna-Liisa Karvonen, Heini Huhtala, Martin Rasmussen, Maarit Salo, Leena Mustaniemi, Ismo Pirttiniemi, Pekka Collin

Listeria infection in patients on anti-TNF treatment: Report of two cases and review of the literature
24 May 2012
Cândida Abreu, Fernando Magro, Filipe Vilas-Boas, Susana Lopes, Guilherme Macedo, António Sarmento
Abstract: Listeria monocytogenes is an aerobic gram positive intracellular bacillus, predominantly affecting pregnant women, immunocompromised patients and old individuals. Invasive listeriosis, menin...
Cutaneous vasculitis in ulcerative colitis mimicking Henoch–Schönlein purpura
24 May 2012
Guilherme Trudes de Oliveira, Sofia Simão Martins, Mariana Deboni, Patrícia Picciarelli, Lúcia Maria Arruda Campos, Adriana Almeida Jesus, Yu Kar Ling Koda, Clovis Artur Silva
Abstract: To the best of our knowledge, no cases of ulcerative colitis (UC) mimicking Henoch–Schönlein purpura (HSP) have been reported so far. During a 28-year period 5635 patients were followed up a...
Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy
24 May 2012
Natasha S. Stephens, Jesse Siffledeen, Xiaorong Su, Travis B. Murdoch, Richard N. Fedorak, Carolyn M. Slupsky
Abstract: Background and aims: Inflammatory bowel disease, a chronic inflammation of the intestinal tract, presents in two variations, Ulcerative Colitis (UC) and Crohn's disease (CD). Given that trea...
Economic impact of combination therapy with infliximab plus azathioprine for drug-refractory Crohn's disease: A cost-effectiveness analysis
24 May 2012
Shota Saito, Utako Shimizu, Zhang Nan, Nozomu Mandai, Junji Yokoyama, Kenshi Terajima, Kouhei Akazawa
Abstract: Background: Combination therapy with infliximab (IFX) and azathioprine (AZA) is significantly more effective for treatment of active Crohn's disease (CD) than IFX monotherapy. However, AZA i...
A patient with ulcerative colitis and central serous chorioretinopathy—A therapeutic dilemma
23 May 2012
Bella Geyshis, Gabriel Katz, Shomron Ben-Horin, Uri Kopylov
Abstract: We report a case of a patient with ulcerative colitis and central serous retinopathy, which is a chronic ophthalmological condition that is frequently aggravated by corticosteroid treatment ...

View More Articles in Press...

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
February 2010 (Vol. 4 | No. 1 | Pages 7-27)
Gert Van Assche, Axel Dignass, Julian Panes, Laurent Beaugerie, John Karagiannis, Mathieu Allez, Thomas Ochsenkühn, Tim Orchard, Gerhard Rogler, Edouard Louis, Limas Kupcinskas, Gerassimos Mantzaris, Simon Travis, Eduard Stange, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (364 KB)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
March 2008 (Vol. 2 | No. 1 | Pages 1-23)
E.F. Stange, S.P.L. Travis, S. Vermeire, W. Reinisch, K. Geboes, A. Barakauskiene, R. Feakins, J.F. Fléjou, H. Herfarth, D.W. Hommes, L. Kupcinskas, P.L. Lakatos, G.J. Mantzaris, S. Schreiber, V. Villanacci, B.F. Warren, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (471 KB)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
February 2010 (Vol. 4 | No. 1 | Pages 28-62)
A. Dignass, G. Van Assche, J.O. Lindsay, M. Lémann, J. Söderholm, J.F. Colombel, S. Danese, A. D'Hoore, M. Gassull, F. Gomollón, D.W. Hommes, P. Michetti, C. O'Morain, T. Öresland, A. Windsor, E.F. Stange, S.P.L. Travis, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (609 KB)
European evidence-based Consensus on the management of ulcerative colitis: Current management
March 2008 (Vol. 2 | No. 1 | Pages 24-62)
S.P.L. Travis, E.F. Stange, M. Lémann, T. Øresland, W.A. Bemelman, Y. Chowers, J.F. Colombel, G. D'Haens, S. Ghosh, P. Marteau, W. Kruis, N.J.McC. Mortensen, F. Penninckx, M. Gassull, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (587 KB)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
February 2010 (Vol. 4 | No. 1 | Pages 63-101)
Gert Van Assche, Axel Dignass, Walter Reinisch, C. Janneke van der Woude, Andreas Sturm, Martine De Vos, Mario Guslandi, Bas Oldenburg, Iris Dotan, Philippe Marteau, Alessandro Ardizzone, Daniel C. Baumgart, Geert D'Haens, Paolo Gionchetti, Francisco Portela, Boris Vucelic, Johan Söderholm, Johanna Escher, Sibylle Koletzko, Kaija-Leena Kolho, Milan Lukas, Christian Mottet, Herbert Tilg, Séverine Vermeire, Frank Carbonnel, Andrew Cole, Gottfried Novacek, Max Reinshagen, Epameinondas Tsianos, Klaus Herrlinger, Bas Oldenburg, Yoram Bouhnik, Ralf Kiesslich, Eduard Stange, Simon Travis, James Lindsay, for the European Crohn's and Colitis Organisation (ECCO)
- Full Text
- PDF (607 KB)

On the Cover

New Issue Alert

Free Trial Issue

Companion Journal

FREE with your Journal of Crohn's and Colitis Subscription!

ECCO Information

The mission of the European Crohn's and Colitis Organisation (ECCO) is to strive for optimized care for patients with inflammatory bowel diseases (IBD) in all aspects. To this end, ECCO will adopt and further all efforts that lead to an improvement in the use of current therapies and procedures, develop guidelines with the highest possible process and content quality, and define better and more valid outcome parameters for the therapy of IBD. In addition, ECCO promotes the specialist, postgraduate education in IBD and scientific projects in IBD.

Access this journal onSciVerse ScienceDirect

About CROHNS

The Journal of Crohn's and Colitis is the official journal of the European Crohn's and Colitis Organisation (ECCO) and is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to inflammatory bowel diseases. The journal publishes original articles, review papers, editorials, leading articles, viewpoints, case reports, innovative methods and letters to the editor. All submitted material is subject to a peer-review process. Supplemental issues of the journal are published under a separate title, Journal of Crohn's and Colitis Supplements.

Journal Access

Access to abstracts is complimentary. Access to full text is limited to print subscribers.

Members of the European Crohn's and Colitis Organisation (ECCO) receive a subscription to the Journal of Crohn's and Colitis as part of their membership benefits. To become a member of ECCO, please visit the ECCO website.

Journal Ranking

Impact Factor of this journal
2010 impact factor: 2.628
© Journal Citation Reports 2011, published by Thomson Reuters

Publishing Information

The Journal of Crohn's and Colitis is published for the European Crohn's and Colitis Organisation (ECCO) by Elsevier.